Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does the Subject's Understanding of Underlying Placebo Mechanisms Compensate for the Loss of Efficacy Associated With the Disclosure of the Use of a Placebo

NCT03934138 is registered in ClinicalTrials.gov with Laboratoire TIMC-IMAG as lead sponsor.

NCT NCT03934138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03934138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does the Subject's Understanding of Underlying Placebo Mechanisms Compensate for the Loss of Efficacy Associated With the Disclosure of the Use of a Placebo
Lead sponsor
Laboratoire TIMC-IMAG
Phase
Not applicable
Overall status
Unknown status
Start date
May 3, 2019
Completion date
September 1, 2020
Enrollment
126 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute pain